首页> 美国卫生研究院文献>Cancer Medicine >Comprehensive characterization of cancer‐testis genes in testicular germ cell tumor
【2h】

Comprehensive characterization of cancer‐testis genes in testicular germ cell tumor

机译:睾丸生殖细胞肿瘤中癌症-睾丸基因的全面表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer‐testis (CT) genes are a group of genes restrictedly expressed in testis and multiple cancers and can serve as candidate driver genes participating in the development of cancers. Our previous study identified a number of CT genes in nongerm cell tumors, but their expression pattern in testicular germ cell tumor (TGCT), a cancer type characterized by less genomic alterations, remained largely unknown. In this study, we systematically investigated the expression pattern of CT genes in TGCT samples and evaluated the transcriptome difference between TGCT and normal testis tissues, using datasets from the UCSC Xena platform, The Cancer Genome Atlas (TCGA) and the Genotype‐Tissue Expression (GTEx) project. Pathway enrichment analysis and survival analysis were conducted to evaluate the biological function and prognostic effect of expressed CT genes. We identified that 1036 testis‐specific expressed protein‐coding genes and 863 testis‐specific expressed long noncoding RNAs (lncRNAs) were expressed in TGCT samples, including 883 CT protein‐coding genes and 710 CT lncRNAs defined previously. The number of expressed CT genes was significantly higher in seminomas (P = 3.48 × 10−13) which were characterized by frequent mutations in driver genes (KIT, KRAS and NRAS). In contrast, the number of expressed CT genes showed a moderate negative correlation with the fraction of copy number altered genomes (cor = −0.28, P = 1.20 × 10−3). Unlike other cancers, our analysis revealed that 96.16% of the CT genes were down‐regulated in TGCT samples, while CT genes in stem cell maintenance related pathways were up‐regulated. Further survival analysis provided evidence that CT genes could also predict the prognosis of TGCT patients with both disease‐free interval and progression‐free interval as clinical endpoints. Taken together, our study provided a global view of CT genes in TGCT and provided evidence that CT genes played important roles in the progression and maintenance of TGCT.
机译:睾丸癌(CT)基因是一组在睾丸和多种癌症中表达受限的基因,可以作为参与癌症发展的候选驱动基因。我们先前的研究在非生殖细胞肿瘤中发现了许多CT基因,但是它们在睾丸生殖细胞肿瘤(TGCT)中的表达模式仍是未知的,这是一种以基因组改变较少为特征的癌症类型。在这项研究中,我们使用UCSC Xena平台,《癌症基因组图谱》(TCGA)和基因型组织表达(),系统地研究了TGCT样品中CT基因的表达模式,并评估了TGCT与正常睾丸组织之间的转录组差异。 GTEx)项目。进行通路富集分析和生存分析,以评估表达的CT基因的生物学功能和预后效果。我们确定TGCT样品中表达了1036个睾丸特异性表达的蛋白质编码基因和863个睾丸特异性表达的长非编码RNA(lncRNA),包括先前定义的883个CT蛋白质编码基因和710个CT lncRNA。在精原细胞瘤中表达的CT基因数量明显更高(P = 3.48×10 −13 ),其特征是驱动基因(KIT,KRAS和NRAS)频繁突变。相反,表达的CT基因的数量与拷贝数改变的基因组的比例呈中等程度的负相关(cor = −0.28,P = 1.20×10 -3 )。与其他癌症不同,我们的分析显示,TGCT样品中96.16%的CT基因被下调,而干细胞维持相关途径中的CT基因被上调。进一步的生存分析提供了证据,CT基因也可以以无疾病间隔和无进展间隔为临床终点来预测TGCT患者的预后。综上所述,我们的研究为TGCT中的CT基因提供了一个整体视图,并提供了证据表明CT基因在TGCT的进展和维持中起着重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号